No Detail Found!

Effect of L-carnitine and Conjugated Linoleic Acid Supplements on Haemoglobin Levels and Haptoglobin Genotype in Chronic Kidney Disease.

Author(s)
Ali Nemati Ardabil University of Medical Sciences,Ardabil,Iran
Reza Alipanah-Moghadam Ardabil University of Medical Sciences,Ardabil,Iran
Mohammad Mazani Ardabil University of Medical Sciences,Ardabil,Iran
Akram Darvishi Ardabil University of Medical Sciences,Ardabil,Iran
Abstract
Objective: To investigate the efficacy of L-carnitine (LC) and conjugated linoleic acid (CLA) supplements on haemoglobin levels and inflammatory markers in chronic kidney disease (CKD) patients with different haptoglobin (HP) genotypes. Methods: This clinical trial study was conducted at Imam Khomeini Hospital, Ardabil, and Labbafinejad Hospital, Tehran, Iran, from March 2014 to March 2015, and comprised male patients with CKD and anaemia. Anthropometric factors were recorded and demographic data was collected using general questionnaires. LC (1 g/day) and CLA (2.4 g/day) supplements were given to the patients for a month. Blood samples were taken to measure haematological and inflammatory markers at the beginning and end of the study. Haptoglobin genotypes were determined using polymerase chain reaction (PCR). SPSS 21 was used for data analysis. Results: Among the 40 patients in the study, HP2-2 genotype was the most prevalent genotype (62.5%). The level of haemoglobin was significantly increased in the patients at the end of the study (p0.05 each). Conclusion: Regular diet supplementation with LC plus CLA can improve haemoglobin levels in CKD patients with anaemia.
Publication Details
Page(s) 343-348
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 69, Issue: 3, Year: 2019

Request the full text from PASTIC

Keywords
Anaemia, 2019), CKD, L-carnitine. (JPMA 69: 343, CLA
0

Citations

0

Downloads

165

Views